Vial Health Technology
Hyper Scalable Biotech
San Francisco, United States · Founded 2020 · $67.0M raised
- Headquarters
- San Francisco, California
- Founded
- 2020
- Business Model
- B2B
- Total Funding
- $67.0M
- Last Round
- $67.0M Series BNov 2022
- Rounds
- 1
About
Vial is a hyper-scalable biotech company advancing a pipeline of potentially best-in-class biologics and RNA therapeutics to treat unmet need in Immunology & Inflammation, using AI-designed target discovery and molecule design. Originally founded in 2020 as Vial Health Technology, providing a technology-enabled clinical trial platform for biotech and pharma sponsors, the company has since evolved into a next-generation pharma company with an integrated, AI-driven drug development approach.
Summary
Vial Health Technology is a Biotech company based in San Francisco, United States, founded in 2020. It has raised $67.0M in total across 1 round, most recently a $67.0M Series B round in Nov 2022. Investors include General Catalyst, BoxGroup and Blake Byers.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...